In conclusion, our results indicate that MnTBAP and possibly other SOD mimetics not only offer a new treatment strategy for obesity and insulin resistance, but may also prove effective against muscle wasting conditions where PKB activity is impaired. Here, SOD1 is linked to obesity disorder.